David Francisco
2021
In 2021, David Francisco earned a total compensation of $1.4M as Chief Financial Officer at Organogenesis Holdings.
Compensation breakdown
| Bonus | $213,875 |
|---|---|
| Option Awards | $658,558 |
| Salary | $331,731 |
| Stock Awards | $218,746 |
| Other | $7,585 |
| Total | $1,430,495 |
Francisco received $658.6K in option awards, accounting for 46% of the total pay in 2021.
Francisco also received $213.9K in bonus, $331.7K in salary, $218.7K in stock awards and $7.6K in other compensation.
Rankings
In 2021, David Francisco's compensation ranked 7,454th out of 12,406 executives tracked by ExecPay. In other words, Francisco earned more than 39.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,454 out of 12,406 | 40th |
Division Manufacturing | 3,276 out of 5,494 | 40th |
Major group Chemicals And Allied Products | 1,449 out of 2,369 | 39th |
Industry group Drugs | 1,290 out of 2,090 | 38th |
Industry Pharmaceutical Preparations | 947 out of 1,537 | 38th |
Source: SEC filing on May 10, 2022.
Francisco's colleagues
We found two more compensation records of executives who worked with David Francisco at Organogenesis Holdings in 2021.